Epidemiology of Rotavirus Infection in North India Community

NCT01508533 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2012-01-12

No results posted yet for this study

Summary

This study was designed to support site preparation and to conduct a disease burden study for the planning and implementation of the phase III trials for the oral rotavirus vaccine 116E.

Conditions

  • Rotavirus Gastroenteritis

Sponsors & Collaborators

  • National Institute of Immunology, New Delhi

    collaborator UNKNOWN
  • Ministry of Science and Technology, India

    collaborator OTHER_GOV
  • Society for Applied Studies

    lead OTHER

Principal Investigators

  • Nita Bhandari, PhD · Society for Applied Studies

Eligibility

Min Age
1 Day
Max Age
24 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2009-09-30
Completion
2010-09-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01508533 on ClinicalTrials.gov